Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells

Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells
复制标题

DOI:
10.1128/jvi.79.20.12692-12702.2005
复制
发表时间:
2005-10-01
影响因子:
5.4
通讯作者:
Ruscetti, FW
Ruscetti, FW
中科院分区:
医学2区
文献类型:
--
作者:
Jones, KS;Petrow-Sadowski, C;Ruscetti, FW

文献摘要

被引文献

相似文献

硫酸乙酰肝素蛋白聚糖(HSPG)被许多病毒用于促进进入宿主细胞。对于逆转录病毒人T细胞白血病病毒1型(HTLV-1),最近报道HSPG对于可溶性HTLV-1 SU的有效结合和HTLV假型病毒进入非T细胞是关键的。然而,据报道,HTLV-1的主要体内靶标CD 4(+)T细胞表达低水平或不可检测水平的HSPG。在这项研究中,我们重新检测了HSPGs在CD 4(+)T细胞中的表达,并检测了它们在HTLV-1附着和进入中的作用。我们观察到,虽然静止的原代CD 4(+)T细胞不表达可检测水平的HSPG,但在免疫激活后,HSPG在原代CD 4(+)T细胞上表达。在已建立的CD 4(+)T细胞系或原代CD 4(+)T细胞表面上的HSPG的酶促修饰显著降低了可溶性HTLV-1 SU和HTLV-1病毒粒子的结合。HSPG也影响HTLV-1进入的效率,因为阻断与HSPG的相互作用显著降低了HTLV-1病毒粒子的内化和CD 4(+)T细胞中HTLV-1假型病毒感染的滴度。因此,HSPG在HTLV-1结合和进入CD 4(+)T细胞中起关键作用。
Heparan sulfate proteoglycans (HSPGs) are used by a number of viruses to facilitate entry into host cells. For the retrovirus human T-cell leukemia virus type 1 (HTLV-1), it has recently been reported that HSPGs are critical for efficient binding of soluble HTLV-1 SU and the entry of HTLV pseudotyped viruses into non-T cells. However, the primary in vivo targets of HTLV-1, CD4(+) T cells, have been reported to express low or undetectable levels of HSPGs. For this study, we reexamined the expression of HSPGs in CD4(+) T cells and examined their role in HTLV-1 attachment and entry. We observed that while quiescent primary CD4(+) T cells do not express detectable levels of HSPGs, HSPGs are expressed on primary CD4(+) T cells following immune activation. Enzymatic modification of HSPGs on the surfaces of either established CD4(+) T-cell lines or primary CD4(+) T cells dramatically reduced the binding of both soluble HTLV-1 SU and HTLV-1 virions. HSPGs also affected the efficiency of HTLV-1 entry, since blocking the interaction with HSPGs markedly reduced both the internalization of HTLV-1 virions and the titer of HTLV-1 pseudotyped viral infection in CD4(+) T cells. Thus, HSPGs play a critical role in the binding and entry of HTLV-1 into CD4(+) T cells.